A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.
Last action: 7-15-2026
Version: 2026012515
Current status: Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.